Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Author(s) -
Aurélien Sokal,
Pascal Chappert,
Giovanna Barba–Spaeth,
A. Roeser,
Slim Fourati,
Imane Azzaoui,
Alexis Vandenberghe,
I. Fernández,
Annalisa Meola,
Magali Bouvier–Alias,
Étienne Crickx,
Asma BeldiFerchiou,
Sophie Hüe,
Laetitia Languille,
Marc Michel,
Samia Baloul,
F. NoizatPirenne,
Marine Luka,
Jérôme Mégret,
Mickaël Ménager,
JeanMichel Pawlotsky,
Simon Fillatreau,
F.A. Rey,
JeanClaude Weill,
ClaudeAgnès Reynaud,
Matthieu Mahévas
Publication year - 2021
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2021.01.050
Subject(s) - biology , memory b cell , germinal center , somatic hypermutation , somatic cell , b cell , antigen , virology , context (archaeology) , affinity maturation , immunology , antibody , repertoire , naive b cell , immune system , t cell , gene , genetics , antigen presenting cell , paleontology , physics , acoustics
Memory B cells play a fundamental role in host defenses against viruses, but to date, their role has been relatively unsettled in the context of SARS-CoV-2. We report here a longitudinal single-cell and repertoire profiling of the B cell response up to 6 months in mild and severe COVID-19 patients. Distinct SARS-CoV-2 spike-specific activated B cell clones fueled an early antibody-secreting cell burst as well as a durable synchronous germinal center response. While highly mutated memory B cells, including pre-existing cross-reactive seasonal Betacoronavirus-specific clones, were recruited early in the response, neutralizing SARS-CoV-2 RBD-specific clones accumulated with time and largely contributed to the late, remarkably stable, memory B cell pool. Highlighting germinal center maturation, these cells displayed clear accumulation of somatic mutations in their variable region genes over time. Overall, these findings demonstrate that an antigen-driven activation persisted and matured up to 6 months after SARS-CoV-2 infection and may provide long-term protection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom